HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monoclonal anti-TL antibody recognizing a TL.2-like antigen.

Abstract
We obtained a monoclonal anti-TL antibody-producing hybridoma by fusion of Sp2/0 hybrid cells with spleen cells from (B6 X A-Tlab) F1 mice immunized with ASL1 leukemia cells. The antibody, TL-22-27-17, reacts in complement-dependent cytotoxicity assay with ASL1 cells as well as with normal thymocytes of TL+ mouse strains (B6-Tlaa, A, BALB/c, DBA/2 and 129) but not with thymocytes from TL- mice (B6--Ly-1a). In addition, it did not react with lymph node cells or Concanavalin A-induced spleen blasts from B6-Tlaa mice; this result shows that TL-22-27-17 recognizes TL and not Qa-1 antigen. The positive reactions with BALB/c (TL.1-2+3-5-6-7+) and 129 (TL.1-2+3-5-6-7-) thymocytes suggest that antibody TL-22-27-17 reacts with TL.2 or TL.2-like antigenic determinant.
AuthorsP Kuśnierczyk, J Szkudlarek, I Steuden
JournalArchivum immunologiae et therapiae experimentalis (Arch Immunol Ther Exp (Warsz)) Vol. 32 Issue 6 Pg. 637-40 ( 1984) ISSN: 0004-069X [Print] Switzerland
PMID6536234 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Membrane Glycoproteins
  • thymus-leukemia antigens
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antigens, Neoplasm (immunology)
  • Membrane Glycoproteins
  • Mice
  • Mice, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: